Bicycle Therapeutics (BCYC) Leases (2019 - 2025)
Bicycle Therapeutics (BCYC) has disclosed Leases for 7 consecutive years, with $4.6 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Leases rose 313.97% year-over-year to $4.6 million, compared with a TTM value of $4.6 million through Sep 2025, up 313.97%, and an annual FY2024 reading of $1.0 million, down 92.16% over the prior year.
- Leases was $4.6 million for Q3 2025 at Bicycle Therapeutics, down from $5.8 million in the prior quarter.
- Across five years, Leases topped out at $18.7 million in Q1 2023 and bottomed at $1.0 million in Q4 2024.
- Average Leases over 5 years is $9.9 million, with a median of $12.0 million recorded in 2024.
- The sharpest move saw Leases soared 1036.9% in 2021, then crashed 92.45% in 2024.
- Year by year, Leases stood at $14.7 million in 2021, then decreased by 6.87% to $13.7 million in 2022, then dropped by 3.58% to $13.2 million in 2023, then plummeted by 92.16% to $1.0 million in 2024, then skyrocketed by 341.63% to $4.6 million in 2025.
- Business Quant data shows Leases for BCYC at $4.6 million in Q3 2025, $5.8 million in Q2 2025, and $6.7 million in Q1 2025.